Latest News Archive

Please select Category, Year, and then Month to display items

UFS launches groundbreaking RPA challenge on innovating with power automation

29 October 2024 | Story Jacky Tshokwe | Photo Supplied

RAiN Automate Innovate Challenge 2024 — The University of the Free State accounting students rise to the challenge in the RAiN Automate to Innovate Challenge.

The School of Accountancy at the University of the Free State (UFS) is leading a forward-thinking initiative by introducing the RAiN Automate to Innovate Challenge in 2024. This marks the first time that the UFS has run this challenge, and it is already making waves in the accounting education landscape. As one the few Accountancy department in South Africa to host such an event, the UFS is paving the way for technological integration in the academic world, setting the stage for future inter-university competitions.

The RAiN Automate to Innovate Challenge invited second-year BAcc students enrolled in the EIDE2724 module to participate in groups of three to four. Their task was to identify and solve a real-world problem related to either students or business by developing a robotic process automation (RPA) bot using Power Automate.

The challenge followed an exploratory learning approach, empowering students to dive into the world of automation with minimal formal lecturing. This approach develops students’ creativity and problem-solving skills. The students worked hard to master Power Automate and applied their knowledge to build automation bots that successfully solved business and student life problems.

Presentations and the final showdown

After presenting their bots on 10, 11, and 14 October, the top six groups were announced in class, eagerly awaiting the grand finale. The final round took place on 18 October from 12:00 to 14:00, where the top six groups competed head-to-head.

A distinguished panel of judges, consisting of three judges from RAiN Auditors and three from the UFS, evaluated the bots based on creativity, functionality, and potential impact. By the end of the event, the winning groups were announced, and the following prizes were awarded:

First place: R1 500 each
Second place: R1 200 each
Third place: R1 000 each

The prizes were generously sponsored by RAiN Auditors, showcasing their commitment to fostering innovation in education.

Looking ahead

As the first South African university to run this type of challenge, the UFS aims to inspire other institutions across the country to follow suit. The School of Accountancy is eager to expand this competition, with the hope of challenging other universities in 2025 and beyond, creating a platform for students to showcase their technical skills and business acumen in the rapidly evolving field of accounting.

Stay tuned for the impact and future growth of the RAiN Automate to Innovate Challenge, where we continue to push boundaries and prepare the next generation of accountants to excel in a digital world.

For more insight into the competition, check out the video recap [here](insert Vimeo link). Be sure to explore the image gallery, showcasing the incredible work and teamwork of our students.

Check out the video here for more details.

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept